Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial
Titel:
Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial
Auteur:
Brahmer, Julie R Rodríguez-Abreu, Delvys Robinson, Andrew G Hui, Rina Csőszi, Tibor Fülöp, Andrea Gottfried, Maya Peled, Nir Tafreshi, Ali Cuffe, Sinead O'Brien, Mary Rao, Suman Hotta, Katsuyuki Zhang, Jin Lubiniecki, Gregory M Deitz, Anne C Rangwala, Reshma Reck, Martin